Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Roy-Chaudhury P, Kelly BS, Melhem M, Zhang J, Li J, Desai P, Munda R, Heffelfinger SC (2005) VA in hemodialysis: issues, management, and emerging concepts. Cardiol Clin 23(3):249–273
2. Shah R, Bhatt UY, van Cleef S, Farley M, Davies A, Swope M, Agarwal AK (2011) VA thrombosis and interventions in patients missing hemodialysis sessions. Clin Nephrol 76(6):435–439
3. 2018 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
4. Thamer M, Lee TC, Wasse H, Glickman MH, Qian J, Gottlieb D, Toner S, Pfelderer TA (2018) Medicare costs associated with arteriovenous fistulas among US hemodialysis patients. Am J Kidney Dis 72(1):10–18
5. Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, Allon M, Asif A, Astor BC, Glickman MH, Graham J, Moist LM, Rajan DK, Roberts C, Vaachhrajani TJ, VAlentini RP (2020) KDOQI VA Guideline Work Group. KDOQI VA Guideline Work Group KDOQI clinical practice guideline for VA: 2019 update. Am J Kidney Dis 75(4(suppl 2)):S1–S164